Edition:
United States

Apricus Biosciences Inc (APRI.OQ)

APRI.OQ on NASDAQ Stock Exchange Capital Market

0.40USD
20 Jul 2018
Change (% chg)

$-0.01 (-2.91%)
Prev Close
$0.41
Open
$0.42
Day's High
$0.42
Day's Low
$0.39
Volume
81,889
Avg. Vol
146,516
52-wk High
$3.34
52-wk Low
$0.25

Select another date:

Thu, May 3 2018

BRIEF-Apricus Biosciences Q1 Loss Per Share $0.14

* APRICUS BIOSCIENCES PROVIDES CORPORATE UPDATE AND FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Apricus Biosciences Says Co Received A Nasdaq Staff Deficiency Letter

* APRICUS BIOSCIENCES SAYS ON APRIL 10, CO RECEIVED A NASDAQ STAFF DEFICIENCY LETTER - SEC FILING Source : https://bit.ly/2JMowAJ Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apricus mulls options; to sell U.S. rights to Vitaros

Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug Administration asked it to make a new formula for the product.

UPDATE 2-Apricus mulls options; to sell U.S. rights to Vitaros

* Co has lost $65 mln in market cap since Feb rejection of Vitaros (Adds details on options, background, shares)

BRIEF-Sabby Management LLC Reports 7.68 Pct Passive Stake In Apricus Biosciences

* SABBY MANAGEMENT LLC REPORTS 7.68 PERCENT PASSIVE STAKE IN APRICUS BIOSCIENCES INC AS OF MARCH 28 - SEC FILING Source text : http://bit.ly/2GhQHcF Further company coverage:

BRIEF-Apricus Biosciences Announces Pricing Of $3.55 Mln Public Offering

* APRICUS BIOSCIENCES ANNOUNCES PRICING OF $3.55 MILLION PUBLIC OFFERING

BRIEF-Apricus Biosciences Announces Proposed Public Offering

* APRICUS BIOSCIENCES INC - COMMENCED A PUBLIC OFFERING OF SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE SHARES OF COMMON STOCK Source text for Eikon: Further company coverage:

BRIEF-Sarissa Capital Management Entered Into Warrant Amendment Agreement With Apricus Biosciences

* SARISSA CAPITAL MANAGEMENT LP SAYS ON MARCH 21, ENTERED INTO WARRANT AMENDMENT AGREEMENT WITH APRICUS BIOSCIENCES INC - SEC FILING

BRIEF-Apricus Biosciences Inc Files ‍Prospectus Relates Offering Of Up To 2 Million Shares Of Co's Common Stock By Selling Stockholders - SEC Filing​

* APRICUS BIOSCIENCES INC FILES ‍PROSPECTUS RELATES OFFERING OF UP TO 2 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING​ Source text: (http://bit.ly/2tbNSUG) Further company coverage:

BRIEF-Apricus Biosciences Q4 Loss Per Share $0.16

* APRICUS BIOSCIENCES PROVIDES CORPORATE UPDATE, FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Select another date: